Research

Experts from government, academia, industry, and non-profit organizations put forward recommendations that provide a roadmap for an integrated, multidisciplinary research agenda necessary to inform priorities for Alzheimer’s disease and related dementias. 

A recent study published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, confirmed what many may have assumed – when it comes to Alzheimer’s disease, there is a stigma. Often, this stigma serves as a barrier to research study participation because people are nervous about being discriminated against. By understanding the biggest concerns, it’s hoped that programs and policies can be developed to reduce the stigmas and offer more protections.

A study published last month suggests that a Mediterranean diet isn’t just good for your heart and waistline but can also stave off the onset of Alzheimer’s disease by as much as three-and-a-half years.

Currently, several trials are trying to develop therapies for AD by 2025. These trials’ success, however, depends upon participants who are willing to undergo genetic and biomarker testing to learn if they are at risk of AD dementia. 

To address increasing concerns about difficulties in reaching study recruitment goals, the NIA, with co-facilitation from the Alzheimer’s Association and other organizations, is asking a wide range of stakeholders, particularly those underrepresented in research, to help develop a comprehensive National Strategy for Alzheimer’s Disease Clinical Research Recruitment and Participation.